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The D76N variant of human β2-microglobulin 
(β2m) is the causative agent of a hereditary 
amyloid disease. Interestingly, D76N-associated 
amyloidosis has a distinctive pathology compared 
with aggregation of wild-type (WT) β2m which 
occurs in dialysis-related amyloidosis. A folding 
intermediate of WT-β2m, known as the IT-state, 
which contains a non-native trans Pro32, has been 
shown to be a key precursor of WT-β2m 
aggregation in vitro. However, how a single amino 
acid substitution enhances the rate of aggregation 
of D76N-β2m and gives rise to a different amyloid 
disease remained unclear. Using real-time 
refolding experiments monitored by CD and 
NMR, we show that the folding mechanisms of 
WT- and D76N-β2m are conserved in that both 
proteins fold slowly via an IT-state that has similar 
structural properties. Surprisingly, however, direct 
measurement of the equilibrium population of IT 
using NMR showed no evidence for an increased 
population of the IT-state for D76N-β2m, ruling out 
previous models suggesting that this could explain 
its enhanced aggregation propensity. Producing a 
kinetically trapped analogue of IT by deleting the 
N-terminal six amino acids increases the 
aggregation rate of WT-β2m, but slows 
aggregation of D76N-β2m, supporting the view 
that while the folding mechanisms of the two 
proteins are conserved, their aggregation 
mechanisms differ. The results exclude the IT-state 
as the cause of the rapid aggregation of D76N-
β2m, suggesting that other non-native states must 
cause its high aggregation rate. The results 
highlight how a single substitution at a solvent-
exposed site can affect the mechanism of 
aggregation and the resulting disease. 
 
 
β2-microglobulin (β2m) is a component of the 
major histocompatibility complex class 1 (MHC-
1) which plays an important functional role in 
antigen presentation (1,2). The MHC-1 complex 
consists of a monomeric heavy chain which is non-
covalently assembled with a monomer of β2m 
during its biosynthesis in the endoplasmic 
reticulum (3). Wild-type (WT) human β2m (WT-
β2m) is a 99 residue, ∼12 kDa protein with a seven 
stranded β-sandwich structure that is stabilised by 
a single disulfide bond between residues Cys25 
and Cys80 (Fig. 1a) (4,5). As part of its normal 
catabolic cycle WT-β2m dissociates from the 
MHC-1 complex, and is cleared from the serum 
via the kidneys (6). However, in individuals 
undergoing long-term haemodialysis for kidney 
failure, WT-β2m is not cleared effectively from the 
serum, resulting in an increase in its concentration 
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from an average of 0.16 μM (five healthy subjects) 
to 3.2 μM (eleven patients) (6). The increased 
serum concentration contributes towards the 
formation of amyloid fibrils which typically 
deposit in collagen-rich joints, resulting in 
pathological bone and joint destruction in the 
disorder known as dialysis-related amyloidosis (6-
8). 
The folding pathway of WT-β2m proceeds via 
a long-lived, structured, folding intermediate 
known as IT (9-11). The slow rate of conversion 
from IT to the native state (N-state) is caused by 
the necessary conversion of the peptidyl prolyl 
bond between His31 and Pro32 from a trans to cis 
configuration (11-13). Substitution of Pro32 with 
natural or non-natural amino acids has shown that 
the equilibrium population of the IT-state is 
directly proportional to the aggregation rate of 
WT-β2m (11-15). Consistent with this finding, a 
truncated form of WT-β2m in which the N-
terminal six residues have been removed, enabling 
relaxation of Pro32 from cis to trans, aggregates 
more rapidly than WT-β2m, presumably because 
this variant (known as ΔN6-β2m) cannot escape 
the IT-state (16). ΔN6-β2m is thus a structural 
mimic of the IT-state, and this is supported by the 
similarity of its 1H-15N-HSQC and far-UV CD 
spectra with those of the IT-state populated 
transiently during real-time refolding experiments 
(12,16). 
In 2012, the first naturally-occurring β2m 
variant was identified in a French family as the 
causative agent of a hereditary, late-onset, fatal 
and systemic amyloid disease (17). The amyloid 
fibrils that deposit in the visceral organs of these 
patients were shown to contain exclusively D76N-
β2m, despite the individuals being heterozygous 
for the mutation, having normal renal function and 
normal serum β2m levels (0.11 – 0.13 µM) (17). 
Indeed, proteomic analysis of ex vivo amyloid 
fibrils from these patients failed to detect any WT- 
or ΔN6-β2m, nor was any truncated D76N-β2m 
detected (17). Moreover, no other common 
amyloid proteins were identified in these deposits 
by immunohistochemical staining. Most 
intriguingly, while WT-β2m does not aggregate in 
vitro at neutral pH, unless additives such as 
organic solvents, vigorous agitation, collagen or 
glycosaminoglycans are included (18-20) or the 
protein is truncated at the N-terminus (creating 
∆N6-β2m) (21), D76N-β2m aggregates rapidly at 
neutral pH without the need of these interventions 
(17). 
Various studies have been performed to try to 
rationalise the difference in the aggregation 
propensities of WT- and D76N-β2m. Since the IT-
state is known to be critically important for WT-
β2m aggregation, the folding pathway of D76N-
β2m was investigated by Mangione et al. using 
classical guanidine HCl-induced 
refolding/unfolding experiments, monitored by 
tryptophan fluorescence (22). These experiments 
suggested that D76N-β2m folds similarly to WT-
β2m, with an initial rapid phase followed by a slow 
phase corresponding to the trans to cis 
isomerisation of Pro32 (22). Based on analysis of 
the kinetic data, the authors concluded that D76N-
β2m populates the IT-state to ca. 25 % at 
equilibrium, in marked contrast with its population 
of only ca. 5 % for WT-β2m, rationalising the 
increased amyloidogenicity of D76N-β2m (22). In 
silico studies have also suggested that the IT-state 
of D76N-β2m is structurally distinct to that of WT-
β2m (23,24), raising the possibility that these 
structural differences may also contribute to the 
enhanced aggregation propensity of D76N-β2m. 
Indeed, one such report suggested that the D76N-
β2m IT-state has a larger solvent-exposed surface 
area, a more disordered D-strand and a greater 
solvation free energy than the WT-β2m IT-state, all 
of which were proposed to contribute to the 
enhanced aggregation propensity of the protein 
(23). Alternative models (25) suggest instead that 
D76N-β2m forms two different IT-state structures: 
the first being the same as the WT-β2m IT-state and 
the second being unique to D76N-β2m by having 
unfolded N- and C-terminal regions. Interestingly, 
the second D76N-β2m IT-state was suggested to be 
more prone to oligomerisation, its formation thus 
rationalising the rapid aggregation of D76N-β2m 
(25). 
To cast more light on the reasons for the 
enhanced amyloidogenicity of D76N-β2m, and 
specifically to distinguish between these different 
models, we analysed the population and structure 
of the D76N-β2m IT-state directly using real-time 
refolding experiments monitored by far-UV CD 
and heteronuclear NMR. These experiments 
provide direct structural and kinetic insights into 
the intermediate(s) formed during folding (26). 
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The aggregation propensity of the D76N-β2m IT-
state was also probed via the generation of an IT-
state structural mimic at equilibrium by truncation 
of the N-terminal six amino acids of D76N-β2m 
(named ΔN6-D76N-β2m), inspired by the ΔN6-
β2m variant (16). These results revealed that 
D76N-β2m folds through an IT-state that 
structurally mimics the IT-state of WT-β2m. 
Importantly, direct measurement of the population 
of the D76N-β2m IT-state at equilibrium using 
NMR revealed that this species is only rarely 
populated at equilibrium (the IT-state is below the 
detection threshold of 1H-15N-HSQC experiments 
at equilibrium) ruling out models which suggest an 
enhanced concentration of the IT-state as the 
rationale for the increased aggregation kinetics of 
D76N-β2m. Instead, we posit that the mutation of 
Asp to Asn, specifically at position 76 (27), alters 
the aggregation mechanism of β2m substantially, 
such that the rate of aggregation no longer depends 




D76N-β2m folds via an IT-state that structurally 
resembles the IT-state of WT-β2m 
Despite sharing a common immunoglobulin 
fold and differing only in a single amino acid 
substitution at a solvent exposed site (Fig. 1a), 
D76N-β2m aggregates rapidly at neutral pH, whilst 
WT-β2m does not aggregate into amyloid fibrils 
under the same conditions in vitro (Fig. 1b) (17). 
This raises the possibility that the difference in 
aggregation behaviour of the two proteins could 
result from differences in (i) the population of a 
common amyloidogenic IT-state, (ii) the structural 
properties of the IT-state, or (iii) the proteins’ 
aggregation mechanisms, such that D76N-β2m 
does not aggregate via the IT-state. To distinguish 
between these possibilities, we examined the 
conformational properties of the IT-states of WT- 
and D76N-β2m by real-time folding experiments 
monitored using far-UV CD and compared them 
with those of ΔN6-β2m. D76N- and WT-β2m have 
essentially identical native protein structures with 
a root-mean-square deviation (RMSD) of 0.3 Å 
(Fig. 1a) as well as identical far-UV CD spectra 
(Supplementary Fig. S1). Despite an RMSD 
between ΔN6- and WT- or D76N-β2m of only 1.8 
Å and 1.9 Å, respectively (Fig. 1a), the far-UV CD 
spectrum of ΔN6-β2m has a larger negative 
maximum at 216 nm than WT- or D76N-β2m 
(Supplementary Fig. S1), presumably resulting 
from differences in the arrangement of aromatic 
sidechains in the core of the proteins (14,28). 
Analysis of the CD spectra of Pro32 variants of 
β2m reported similar differences, and showed 
(assuming a two-state model) that the relative 
population of the IT- and N-states at equilibrium 
can be deduced directly from these spectra (14). 
Building on these results, WT- and D76N-β2m 
were each unfolded at acidic pH (Experimental 
Procedures). Folding was then initiated by rapidly 
increasing the pH to 7.4, and far-UV CD spectra 
were acquired as a function of time until folding 
was complete (Fig. 2a, b). ΔN6-β2m, which is 
trapped at equilibrium in an IT-like state at pH 7.4, 
was similarly treated and included for comparison 
(Fig. 2c). The results showed, as expected (22), 
that both WT- and D76N-β2m fold rapidly (in less 
than a minute) to an IT-like state, yielding a far-UV 
CD spectrum with an intense negative maximum 
at 216 nm that is larger than that of their N-states 
and typical of that expected for a solution 
containing a significantly population of the IT-state 
(16,22). Subsequent to this transition, slow 
refolding to the N-state occurs, which involves a 
decrease in signal intensity in the far-UV CD (Fig. 
2a, b). The refolding rate constant for this phase, 
which maps the IT- to N-state transition, was 1.03 
x 10–3 ± 0.03 x 10–3 s-1 and 1.27 x 10–3 ± 0.03 x 10–
3 s-1 for WT- and D76N-β2m, respectively, 
indicating that WT- and D76N-β2m fold to the N-
state with similar rates (Fig. 2a, b). Consistent with 
this interpretation, the slow phase is absent for 
ΔN6-β2m as this variant remains trapped in an IT-
like state (Fig. 2c). These experiments confirm 
previous results which suggested that D76N-β2m 
folds slowly to its N-state via an IT-like species 
(16,22), and reveal that this species resembles the 
IT-state of the WT protein, at least as judged by its 
far-UV CD spectrum. 
To obtain more detailed information about the 
structural properties of the D76N-β2m IT-state, 
refolding was also monitored in real-time using 
NMR. We first obtained a full backbone resonance 
assignment for native D76N-β2m, as this 
information was not available in the BMRB 
(Experimental Procedures). Refolding experiments 
were initiated by rapidly increasing the pH of the 
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acid-unfolded proteins to pH 7.4. The first 1H-15N-
SOFAST-HMQC spectra of WT- and D76N-β2m 
obtained 90 sec after the initiation of refolding 
show well-dispersed peaks, consistent with the 
presence of the structured IT-state which is 
expected to dominate the refolding reaction at this 
time point (Fig. 3a and Supplementary Figs. S2 & 
S4). It is interesting to note that ~14 % and ~13 % 
of the species populated at this time correspond to 
native WT- and D76N-β2m, respectively, as 
judged by the intensity of resonances unique to the 
N-state in each spectrum. Importantly, these 
spectra are distinct from those of the earlier 
intermediate of WT-β2m (I1) and murine β2m 
observed previously using non-uniform sampling 
NMR methods which gives rise to very broad 
spectra and species shown not to be amyloidogenic 
(29). As expected, the spectra of the IT-states of 
WT- and D76N-β2m are very similar to one 
another (Fig. 3a), as well as to spectra previously 
observed for the WT-β2m IT-state (22) and ΔN6-
β2m (16) (obtained under similar conditions, with 
identical pH and salt concentrations). Using the 
previously assigned ΔN6-, WT-, and D76N-β2m 
spectra in combination, amino acid assignments 
were transferred to the spectra acquired after a 90 
sec refolding time (Supplementary Figs. S2 & S4). 
69 peaks were successfully assigned for WT-β2m 
and 58 for D76N-β2m, allowing the chemical shifts 
of resonances in the IT-states of WT- and D76N-
β2m to be compared (Fig. 3b). This showed that 
significant chemical shift perturbations (CSPs) are 
observed only for residues in the EF-loop (residues 
71 to 78, which contains the D76N substitution) 
and the structurally adjacent AB-loop (residues 12 
to 20) (Fig. 1a and Fig. 3b). The 1H-15N-SOFAST-
HMQC spectra of native (N-state) WT- and 
D76N-β2m (obtained after a folding time of 180 
min (Supplementary Figs. S3 & S4) are also 
similar, with the only significant chemical shift 
differences again involving residues in the AB- 
and EF-loops (Fig. 3d). The similar CSPs between 
WT- and D76N-β2m at 90 sec (IT-state) and 180 
min (N-state) refolding times (Fig. 3b, d) show 
that the folding of both proteins involves a 
kinetically long-lived IT-state that has similar 
structural properties for both β2m variants, at least 
as judged by these approaches. 
 
The β2m folding energy landscape is 
unperturbed by the D76N substitution 
Given the similarities in the folding 
mechanisms of WT- and D76N-β2m, the 
remarkable difference in their rates of aggregation 
into amyloid could result from differences in the 
population of the IT-state at equilibrium, which 
would be reflected by differences in the rate of 
folding/unfolding of IT-state to/from the N-state. 
Indeed, such a scenario was posited previously 
based on analysis of their folding kinetics using 
tryptophan fluorescence (22). Consistent with this 
view, the population of the IT-state in WT-β2m 
variants (such as P32G-, P5G- and ΔN6-β2m) have 
been shown to correlate with their aggregation 
rates (14). The rate of the IT- to N-state transition 
of WT- and D76N-β2m was investigated at the 
single residue level by fitting the 1H-15N-
SOFAST-HMQC peak volumes for resonances 
which have a unique chemical shift in their N-
states (i.e. they do not overlap with peaks arising 
from IT-state). For WT-β2m/D76N-β2m 70/66 
peaks could be identified as unique to their N-
states (Supplementary Figs. S3 & S5). The 
intensity of these peaks was monitored as a 
function of the refolding time and fitted to a single 
exponential function (Experimental Procedures) 
(Fig. 4a-d), from which 40/37 per-residue 
refolding rate constants, respectively, could be 
determined with confidence (Fig. 4e, f). Of note is 
that the peak volume is not zero in the initial 
spectrum obtained after 90 sec, reflecting a small 
population (<15%) of molecules that fold rapidly 
to the N-state presumably since they represent the 
small population of molecules with a cis Pro32 in 
the unfolded state (Fig. 4a-d). The data revealed 
that the IT- to N-state transition proceeds at a 
similar rate for all residues monitored for WT- and 
D76N-β2m, with median rate constants of 0.62 x 
10-3 ± 0.05 x 10-3 s-1 and 0.63 x 10-3 ± 0.04 x 10-3 s-
1, respectively. Hence the energy barrier for the IT- 
to N-state transition is similar for both proteins. 
A similar kinetic analysis was carried out 
focusing on peaks which are unique to the IT-state, 
(i.e. they do not overlap with peaks rising from N-
state) (Supplementary Fig. S6). In the spectra 
obtained after a 90 sec refolding time, 26/25 peaks 
are unique to the IT-states for WT-β2m/D76N-β2m, 
respectively (Supplementary Figs. S2 & S4). The 
intensity of these peaks was also monitored as a 
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function of the refolding time and fitted to a single 
exponential (Experimental Procedures) 
(Supplementary Fig. S6a-d), from which 20/19 
per-residue refolding rate constants for WT- and 
D76N-β2m, respectively, could be determined with 
confidence (Supplementary Fig. S6e, f). This 
analysis also showed similar kinetic behaviour for 
WT- and D76N-β2m, with the decrease in intensity 
of IT-state peaks occurring with median rate 
constants of 0.56 x 10-3 s-1 ± 0.06 x 10-3 s-1 and 
0.49 x 10-3 ± 0.05 x 10-3 s-1, respectively 
(Supplementary Fig. S6e, f). The similarity in rate 
constants for different residues throughout the 
protein sequence for these transitions provides 
strong evidence in support of a two-state IT- to N-
state transition. In addition, the results show that 
the energy barrier between the IT-state and the N-
state is essentially unperturbed by the D76N 
substitution. 
The unique chemical shifts for residues in the 
IT- and N-states also enable the equilibrium 
populations of the IT- and N-states in WT- and 
D76N-β2m to be directly determined using NMR. 
Previous results have shown that the population of 
the IT-state is less than 5 % for WT-β2m at 
equilibrium under the conditions used (22). 
Consistent with this, despite contouring into the 
noise of the native WT-β2m spectrum, resonances 
unique to the IT-state could not be observed. The 
lowest contour level of this spectrum is 12-fold 
below that of the other spectra shown (Fig. 5a). 
Despite high signal-to-noise of these spectra, no 
evidence for resonances which are unique to the 
IT-state of WT-β2m could be observed in the noise 
of its N-state spectrum (see for example 
resonances for Ser11 and Ser52 in Fig. 5a), 
implying a low equilibrium population of the IT-
state. Importantly, the lack of detectable IT-state 
resonances in the spectrum of native D76N-β2m 
(Fig. 5b) demonstrates a similar low equilibrium 
population of IT-state for this protein, consistent 
with the similarities of these variants’ far-UV CD 
spectra presented in Supplementary Fig. S1. Thus, 
the D76N-β2m IT-state has similar structure, 
relative population and interconversion rates with 
the N-state as the WT-β2m IT-state, providing clear 
evidence that the amyloidogenicity of D76N-β2m 
cannot be attributed to differences in the IT-state. 
 
Generation of a kinetically-trapped D76N-β2m 
IT-state mimic 
In order to determine the aggregation 
propensity of the D76N-β2m IT-state directly, a 
truncated product of the D76N-β2m variant was 
produced in which the N-terminal six residues 
were removed, inspired by previous findings that 
ΔN6-β2m mimics the IT-state of WT-β2m 
(16,29,30), referred to as ΔN6-D76N-β2m 
(Experimental Procedures). As anticipated, the 1H-
15N-SOFAST-HMQC spectrum of this variant 
closely resembles the spectrum of the D76N-β2m 
IT-state captured transiently during refolding, 
indicating that ΔN6-D76N-β2m is indeed an IT-
state mimic of D76N-β2m (Fig. 6a). Interestingly, 
measurement of the rate of aggregation of the 
different proteins into amyloid fibrils using ThT 
fluorescence showed that ΔN6-D76N-β2m is less 
aggregation-prone than its full-length counterpart, 
by contrast with truncation of the N-terminal six 
residues from WT-β2m which dramatically 
increases the rate of its aggregation (compare Fig. 
1b and Fig. 6b). Fitting the normalised ThT 
fluorescence intensity data yielded aggregation 
half-time (Thalf) values of 24.7 ± 9.5 h for ΔN6-
D76N-β2m, 18.0 ± 1.9 h for ΔN6-β2m and 6.6 ± 
0.7 h for D76N-β2m (Table 1). Hence, of these 
three variants, D76N-β2m aggregates most rapidly 
despite containing a cis Pro32 and an intact N-
terminal sequence. 
Finally, the effect of deleting the N-terminal 
six residues on the stability of D76N-β2m was 
measured using temperature denaturation 
monitored by far-UV CD (Fig. 6c). The results 
revealed an apparent midpoint temperature (Tm,app) 
of denaturation (Table 1) with the rank order of 
stability ΔN6-D76N-β2m < D76N-β2m ~ ΔN6-β2m 
< WT-β2m. The results demonstrate that the Thalf 
aggregation does not correlate with 
thermodynamic stability. Interestingly, the results 
also showed that the difference in Tm,app between 
ΔN6- and WT-β2m is 10.3 °C, a value similar to 
that obtained by deletion of the N-terminal six 
residues in D76N-β2m (11.8 °C) (Table 1). Thus, 
there is little cross-talk between the N-terminal 
hexapeptide and the effect of the amino acid 
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The native-like folding intermediate of WT-
β2m, known as the IT-state, is central to the 
mechanism of its assembly into amyloid (14,31). 
Here, we have examined in detail the contribution 
of the IT-state to the aggregation mechanism of the 
closely-related D76N-β2m variant, building on 
previous results which suggested that the 
population and/or structural properties of this state 
could rationalise the dramatically enhanced ability 
of the protein to aggregate into amyloid both in 
vitro and in vivo (22). The slow folding rate of 
WT- and D76N-β2m was exploited here to enable 
direct analysis of the IT- to N-state transition using 
real-time far-UV CD and NMR spectroscopy. The 
results revealed that D76N-β2m folds via an IT-
state which structurally resembles the WT-β2m IT-
state. Analysis of the refolding kinetics in residue-
specific detail showed that the activation barrier 
between the IT- and N-states in WT- and D76N-
β2m is similar. This implies a similar degree of 
destabilisation of the IT-state, transition state and 
N-state by the substitution of Asp to Asn at 
position 76 (in agreement with all species having 
native-like structural properties). Moreover, the 
relative populations of the IT- and N-state at 
equilibrium are also not perturbed by the D76N 
substitution. Hence, by contrast with previous 
reports (22), our evidence shows that the enhanced 
amyloidogenicity of D76N-β2m cannot be 
explained by increased population of IT-state or by 
any substantial differences in its structural 
properties (although subtle differences in 
conformation not reflected in 1H/15N chemical 
shifts cannot be ruled out). Finally, the decreased 
stability of D76N-β2m relative to the WT protein 
does not explain its increased amyloid potential, 
since other β2m variants with similar or even 
further reduced stability compared with D76N-
β2m, including murine-β2m (29), V37A-β2m (32) 
and the ΔN6-D76N-β2m variant described here,  
all aggregate more slowly than D76N-β2m. 
The similarity of the WT- and D76N-β2m IT-
states is further suggested by the similarity in the 
aggregation rates of ΔN6- and ΔN6-D76N-β2m, 
both of which are presumably trapped in an IT-like 
state. Strikingly, this rate is slower than that of the 
parent D76N-β2m variant, demonstrating that 
while the D76N-β2m IT-state is aggregation-prone, 
its formation cannot be rate-determining for 
aggregation of the full-length protein. This 
suggests that D76N-β2m aggregates by a 
mechanism distinct from that of its WT 
counterpart for which the IT-state population 
determines the rate of aggregation. Instead 
aggregation of D76N-β2m could be initiated by 
formation of a different non-native, but structured 
species, possibly the previously identified N*-state 
observed in D76N-β2m crystals (33). 
Alternatively, aggregation may occur from more 
highly disordered state(s) of the protein, with the 
D76N substitution increasing the amyloidogenicity 
of these species by altering their conformational 
properties. Such a mechanism has been posited for 
immunoglobulin light chains associated with light 
chain amyloidosis based on the orientation of the 
two β-strands linked by the disulfide bond in the 
native monomer and in the amyloid fold (34). In 
addition, the role of flanking regions in tailoring 
amyloidogenicity has been observed in several 
other proteins that aggregated from a disordered 
state, including α-synuclein (35) and tau (36). A 
different aggregation pathway and precursor 
species in D76N-β2m could also explain the subtle 
differences in the WT- and D76N-β2m fibril 
secondary structures determined using solid state 
NMR and/or cryo-electron microscopy (EM) 
(33,37-40). 
In summary, the results presented here 
demonstrate that the mechanisms of aggregation of 
WT- and D76N-β2m differ significantly, with the 
WT protein aggregating via formation of the IT-
state, while for D76N-β2m a different native-like-
state (N*-state) (33) or perhaps a more highly 
unfolded state (41) could be rate-determining for 
aggregation. These differences in mechanism, 
involving different precursor(s), may also explain 
the radical differences between the systemic 
amyloidosis caused by D76N-β2m and the 
pathology of dialysis-related amyloidosis caused 
by the WT protein. Indeed, at normal serum 
concentrations, D76N-β2m aggregates into 
amyloid without involvement of the WT protein in 
these heterozygous individuals (22). By contrast, 
for WT-β2m aggregation involves truncation of the 
N-terminus to form ΔN6-β2m, the isomerisation of 
cis Pro32 to trans (29,30), and the involvement of 
collagen, glycosaminoglycans and other 
extracellular factors to create amyloid that deposits 
specifically in the joints (18,32,42,43). Our results 
thus highlight the fundamental difference in the in 
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vitro aggregation mechanism and the 
consequences in diseases brought by a single 
amino acid substitution in a solvent-exposed loop 





Protein expression and purification 
14N-, 15N-, and 15N-13C-labelled proteins were 
expressed and purified as described previously 
(30). D76N-ΔN6-β2m was particularly prone to 
precipitation when resuspending the lyophilised 
material during purification, and so care was taken 
to ensure that resuspension was always carried out 
in 20 mM sodium phosphate, pH 7.4. All proteins 
were purified in the last step using gel filtration 
and care was taken to only collect the centre of the 
monomer peak so as to exclude the possibility of 
oligomers in the preparations. Analysis using 
SEC-MALLS, native ESI-MS and by re-injecting 
the protein onto the column after concentration did 
not reveal the detectable presence of oligomers in 
the preparations. 
 
Real-time refolding monitored by far-UV CD 
Proteins (30 μM) were dialysed against the 
unfolding solution (0.8 M urea, 25 mM sodium 
phosphate buffer at pH 2.5) for 1 h. To initiate 
refolding, the unfolded proteins were rapidly 
diluted with 300 mM sodium phosphate buffer, pH 
7.4 (2:1 (v/v) unfolded protein:refolding buffer) at 
20 °C. Data acquisition was initiated immediately 
after addition of the refolding buffer into the CD 
cuvette which already contained the unfolded 
protein (dead-time ~ 1 sec). Spectra (200-260 nm) 
were acquired using a ChirascanTM plus CD 
spectrometer (Applied Photophysics). One 
spectrum was recorded per min, using a step size 
of 1 nm and a sampling time of 0.5 sec per point.  
 
Real-time refolding monitored using NMR 
Protein samples (450 μM) were dialysed 
against the unfolding solution (1.5 M urea, 25 mM 
sodium phosphate buffer at pH 2.5 containing 10 
% (v/v) D2O) for 1 h. To initiate refolding, 150 μl 
of refolding buffer (500 mM sodium phosphate, 
pH 7.4) was added to 350 μl of each unfolded 
protein (final protein concentration 300 μM in 167 
mM sodium phosphate buffer, pH 7.4). These 
experiments were carried out at 20 °C. The sample 
was immediately added to the NMR tube and data 
acquisition was initiated (dead-time ~ 30 sec). The 
folding reaction was monitored by acquiring 1H-
15N-SOFAST-HMQC (44) spectra every 60 sec, 
with 100 points in f1 (15N) and 956 in f2 (1H), and 
two scans were acquired per increment. Spectra 
were recorded on a 600 MHz Bruker AVANCE III 
HD spectrometer equipped with a 5mm QCI-P 
(proton-observe inverse quadruple resonance) 
cryoprobe, using spectral widths of 15.97 ppm in 
f2 and 22.00 ppm in f1. 
Spectra were processed in NMRPipe (45) and 
analysed with the software package PINT (46). 
Peak volumes were determined by fitting to a 
Lorentzian line shape. The total peak volume of 
each residue was plotted as a function of time and 
fitted to a single exponential to determine the 
refolding rate constant: 
y = −𝑎𝑎𝑒𝑒−𝑏𝑏𝑏𝑏 + 𝑐𝑐                        Equation 1 
or 
y = 𝑎𝑎𝑒𝑒−𝑏𝑏𝑏𝑏 + 𝑐𝑐                           Equation 2 
where 𝑦𝑦 is the intensity of the chosen peak at time 
𝑥𝑥, 𝑐𝑐 is the value of 𝑦𝑦 at infinite time, 𝑎𝑎 is the initial 
intensity and 𝑏𝑏 is the rate constant. For positive 
peaks, Equation 1 was used to fit peaks unique to 
the N-state and Equation 2 was used to fit peaks 
unique to the IT-state.  
Chemical shift perturbations (CSPs) were 
calculated using Equation 3: 
𝐶𝐶𝐶𝐶𝐶𝐶 =  ��5𝛿𝛿 𝐻𝐻1 �2 + �𝛿𝛿 𝑁𝑁15 �2          Equation 3 
where 𝛿𝛿 𝐻𝐻1  and 𝛿𝛿 𝑁𝑁15  are the differences in the 1H 
and 15N chemical shifts for the two resonances 
being compared. 
 
Thermal denaturation monitored by far-UV 
CD 
For thermal denaturation experiments an 
initial spectrum of the sample (20 μM protein in 
25 mM sodium phosphate buffer, pH 7.4), was 
obtained at 25 °C. The temperature of the solution 
was decreased to 20 °C, and then increased in 5 °C 
steps with an equilibration time of 120 sec at each 
temperature, up to a final temperature of 90 °C. At 
the end of the temperature ramp, the sample was 
cooled to 25 °C and a spectrum acquired to 
determine if the transition was reversible. Each 
spectrum was acquired from 190 nm to 260 nm 
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with a step size of 1 nm and 1 sec per point 
sampling. Two spectra were acquired for each 
temperature and averaged. The path length used 
was 1 mm. The data were fitted to a two-state 
equilibrium (Equation 4) using the software 
package CDPal (47). 
 












��  Equation 4 
where 𝛥𝛥𝐻𝐻𝑚𝑚 is the change in enthalpy at the 
denaturation midpoint 𝑇𝑇𝑚𝑚, 𝛥𝛥𝐶𝐶𝑝𝑝 is the difference in 
heat capacity between the two states, R is the gas 
constant and T the temperature (Kelvin). 𝛥𝛥𝐶𝐶𝑝𝑝 was 
assumed to be independent of temperature. Since 
the thermal denaturation process was not fully 
reversible, Tm,ap values are quoted. 
 
In vitro fibrillation assays 
Protein samples (stored either as lyophilised 
powder and resolubilised immediately before used 
in 25 mM sodium phosphate buffer pH 7.4, or as 
concentrated solution at -80 °C) were centrifuged 
at 14000 x g for 10 min, the supernatant was 
filtered (0.22 μm, Millipore), diluting the same as 
appropriate to give a final protein concentration of 
30 μM in 25 mM sodium phosphate pH 6.2, 137 
mM NaCl, 10 μM ThT, 0.02 % (w/v) NaN3. Each 
protein (ten replicates, 100 μl each) was added to 
Corning 96 well polystyrene microtiter plates, 
sealed with clear polyolefin film (STARLAB) and 
incubated at 37 °C for at least 48 h with constant 
shaking at 600 rotations per minute (rpm). ThT 
fluorescence was monitored (excitation 440 nm 
and emission 480 nm) with a Fluostar Optima, 
BMG Labtech plate reader. 
Thalf values were calculated by fitting 
normalised data (between 0 to 1) for each replicate 
to Equation 5, and determining the time taken to 
reach half the maximal intensity: 




                 Equation 5 
where 𝐴𝐴 is the pre-transition baseline (lower 
asymptote), 𝐾𝐾 is the post-transition baseline (upper 
asymptote), 𝐵𝐵 is the growth rate and 𝑀𝑀 is the time 
of maximal growth. 𝑄𝑄 and 𝑣𝑣 are parameters which 
affect the transitions from and to the growth phase, 
𝑌𝑌 is the normalised signal and 𝑡𝑡 is time (48,49). 
 
Negative stain transmission EM  
Carbon coated copper EM grids were placed 
coated-side down onto sample drops containing 
undiluted material from the in vitro fibrillation 
assay for 30 sec. The grids were then blotted with 
filter paper to remove excess solvent and sample. 
Grids were then placed onto drops of 2 % (w/v) 
uranyl acetate for 30 sec, blotted again and air-
dried. Images were taken using a Jeol 1400 
microscope using a 120 keV Lab6 filament and 
Gatan US1000XP 2k x 2k CCD camera. 
 
D76N-β2m NMR assignment 
The assignment of D76N-β2m was performed in 
25 mM sodium phosphate, 83 mM sodium 
chloride at pH 7.4 and 25 °C. 15N and 15C 
uniformly labelled protein was used to acquire all 
NMR experiments needed to accomplish the 
backbone and side chains assignment. Triple 
resonance HNCO, HNCA, HN(co)CA, 
HN(co)CACB, (h)CCH-TOCSY, H(c)CH-TOCSY 
NMR experiments were recorded on a Bruker 
AVANCE III HD 750 MHz spectrometer equipped 
with triple resonance inverse cryoprobe. Spectra 
were processed using NMRPipe and analysed 
using CcpNmr Analysis (version 2.4) (50). 
1H, 15N and 13C chemical shifts were 
deposited in the Biological Magnetic Resonance 








All raw data from the results presented will be made available upon request: please contact Sheena 
Radford (s.e.radford@leeds.ac.uk). 1H, 15N and 13C chemical shift assignments for D76N are available at 
BRMB (accession number 50302). 
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weight/volume; RMSD, root-mean-square deviation; v/v, volume/volume 
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Figures and Figure Legends 
 
 
Figure 1. Structure and amyloidogenicity of WT-, D76N- and ΔN6-β2m.  
(a) Superposition of the crystal structures of WT- (blue; PDB: 1LDS (51)) and D76N-β2m (red; PDB: 
4FXL (17)), and the lowest-energy structure of ΔN6-β2m determined using NMR (green; PDB: 2XKU 
(16)). The insets highlight the BC loop, which contains Pro32, and the EF loop, which contains residue 
76. (b) Aggregation kinetics of WT- and D76N-β2m (coloured as (a)) measured using thioflavin T (ThT) 
fluorescence. Experiments were performed with 30 μM protein in 25 mM sodium phosphate pH 6.2, 137 
mM NaCl, 10 μM ThT, 0.02 % (w/v) NaN3, at 37 °C, 600 rpm. 10 replicates are shown. Negative stain 
transmission electron microscopy images of the assay endpoints (taken after 100 h) are shown as insets, 
framed in the same colours. The scale bar corresponds to 300 nm. 
  




Figure 2. Real-time refolding of WT-, D76N- and ΔN6-β2m, monitored by far-UV CD. 
WT-β2m is in blue (a), D76N-β2m is in red (b) and ΔN6-β2m is in green (c). Spectra were recorded every 
minute over the refolding time-course, however only spectra acquired at 10 min intervals are shown here 
for clarity. In all plots, spectra are shaded darker as the time-course progresses. These experiments were 
carried out at 20 °C at a final protein concentration of 20 μM in 100 mM sodium phosphate buffer, pH 
7.4. MRE corresponds to the molar ellipticity. 
  




Figure 3. Real-time refolding of WT- and D76N-β2m, monitored by 1H-15N NMR spectroscopy. 
(a) 1H-15N-SOFAST-HMQC spectra for WT- (blue) and D76N-β2m (red) recorded 90 sec after the 
initiation of refolding by pH jump (Experimental Procedures). Assignments of the 90 sec spectra (IT-state) 
are shown in Supplementary Figs. S2 & S4 for WT- and D76N-β2m, respectively. (b) CSPs between 
spectra of WT- and D76N-β2m shown in (a). The CSP was calculated for the 58 peaks successfully 
assigned for the IT-state of both WT- and D76N-β2m (Supplementary Figs. S2 & S4, respectively). (c) 1H-
15N-SOFAST-HMQC spectra of WT- (blue) and D76N-β2m (red) recorded 180 min after the initiation of 
refolding. (d) CSPs between spectra of WT- and D76N-β2m shown in (c). The CSP was calculated for the 
87 peaks successfully assigned for the N-states of both WT- and D76N-β2m (Supplementary Figs. S3 & 
S5, respectively). (a, c) Only positive contours are shown. 1H-15N resonances for Gly18 and Gly43 are 
therefore not present in this figure as they have negative intensities due to folding of the spectrum in the 
15N dimension. Residues with significant chemical shift differences are labelled. (b, d) CSPs <1σ (dotted 
line) from the mean of all CSPs are coloured in grey; those between 1σ and 2σ are coloured orange and > 
2σ from the mean  are coloured red. CSPs are mapped onto the solution structures of ΔN6- (PDB: 2XKU 
(16)) or WT-β2m (PDB: 2XKS (16)) for (b) and (d), respectively, using the same colour code. These 
experiments were carried out at 20 °C at a final protein concentration of 300 μM in 1.0 M urea and 167 
mM sodium phosphate buffer, pH 7.4.   




Figure 4. Single-residue refolding rates for N-state peaks of WT- and D76N-β2m, monitored by 
NMR spectroscopy. 
(a-d) Representative data and fits in black for single residue folding rates fitted with Equation 1 
(Experimental Procedures). (e, f) The rate constants for individual residues that could be measured with 
confidence (where the error on the fit is no more than 3 median absolute deviations of all errors within 
each dataset) are shown in (e) and (f) for WT- and D76N-β2m, respectively. Error bars are the fitting 
errors.  
  




Figure 5. Searching for IT-state peaks in the N-state 1H-15N-SOFAST-HMQC spectra of native WT- 
and D76N-β2m. 
The spectra of WT- (a) and D76N-β2m (b) taken at 180 min (black contours) after refolding are compared 
with the corresponding spectra taken at 90 sec (blue contours for WT-β2m and red contours for D76N-
β2m). The native protein spectra obtained after a refolding time of 180 min are contoured to show the 
spectral noise (grey) down to a level 12-fold below that of the lowest black contour. The peaks unique to 
the IT-state are labelled in green, those unique to the N-state are labelled in purple and peaks common 
between the IT-state and the N-state are labelled in black. There is no evidence of observable resonances 
from the IT-state in the spectra of the native proteins, consistent with a very low population of IT at 
equilibrium.  
  




Figure 6. Characterisation of ΔN6-D76N-β2m. 
(a) Superposition of the 1H-15N-SOFAST-HMQC spectra of ΔN6-D76N β2m (purple) (80 μM protein in 
25 mM sodium phosphate pH 7.4, 20 °C) and D76N-β2m after 90 sec refolding time (red). The 25 peaks 
unique to the IT-state are labelled in green. (b) Aggregation of ΔN6-D76N- (purple), D76N- (red), ΔN6- 
(green) and WT-β2m (blue) (30 μM protein in 25 mM sodium phosphate pH 6.2, 137 mM NaCl, 10 μM 
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ThT, 0.02 % (w/v) NaN3, 37 °C, 600 rpm). Negative stain transmission EM images of amyloid fibrils 
from reaction endpoint (taken after 100 h) are shown alongside, framed in the same colours. The scale bar 
corresponds to 200 nm. Please note that the ThT curves and EM image for D76N-β2m and WT-β2m are 
reproduced from Fig 1b to allow direct comparison with the other proteins shown. (c) Stability of 
different β2m variants monitored by far-UV CD at 216 nm. The data were fitted using an equation 
describing a two-state exchange model using the CDPal software package (47) for calculation of Tm,app 
values (Experimental Procedures). The temperature ramp experiment was carried out in 25 mM sodium 
phosphate pH 6.2, in the range 20-90 °C in 5 °C steps.  
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Tables and Table Legends 
 
Table 1. Aggregation rates and protein stability of WT-β2m and the three variants (D76N-, ΔN6- 
and ΔN6-D76N-β2m). 
Measurements were made in 30 μM protein in 25 mM sodium phosphate pH 6.2, 137 mM NaCl, 10 μM 
ThT, 0.02 % (w/v) NaN3, 37 °C, 600 rpm for the Thalf, and 30 μM protein in 25 mM sodium phosphate, 
pH 6.2 for the Tm,app.  Note that WT-β2m does not aggregate under the conditions used here over the 
timespan measured.  
 
Variant Aggregation Thalf (h) Tm,app (°C) 
WT-β2m - 65.5 ± 0.5 
D76N-β2m 6.6 ± 0.7 54.6 ± 0.1 
ΔN6-β2m 18.0 ± 1.9 55.2 ± 0.5 
ΔN6-D76N-β2m 24.7 ± 9.5 42.8 ± 0.9 
 
